SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Coherent (COHR) : Anyone else holding?
COHR 128.77-2.5%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Marshall who wrote ()3/11/1999 9:05:00 PM
From: Bob Davis  Read Replies (2) of 788
 
As a leading designer, manufacturer and supplier of equipment using laser technologies, Coherent (NASDAQ:COHR) has been included in a recent study of the dermatological laser industry published in The Napeague Letter.

The valuation tools used by The Napeague Letter indicate that the market currently correctly values COHR, assuming that analyst revenue and earnings projections are met. However, this assumes that the Company will be able to reverse its current financial trends.

Key to the return to revenue and earnings growth is the turnaround of Coherent's Medical Group. Leading indicators of this shift should be an "upward reappraisal" of the Company by the security analysts who follow it, and an improvement in its technical indicators.

Additional information about COHR, including graphics and charts, can be found at napeague.com The Napeague Letter plans to continue to track COHR to watch for signs that a true turnaround is taking place.

Bob Davis
The Napeague Letter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext